Browse studies

Find your next paid study

34 recruiting studies matching your filters

A Double-blind, Double-dummy, Parallel Group, Multicenter Phase 3 Extension Study Evaluating the Long-term Safety and Efficacy of 2 Doses of Remibrutinib in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of remibrutinib (LOU064) in adult participants with moderate to severe…

Hidradenitis Suppurativa

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07665437

Phase 2

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ORKA-002 in Adult Participants With Moderate-to-Severe Hidradenitis Suppurativa

This is a multicenter, randomized, double-blinded, placebo-controlled clinical study of ORKA-002 in adult participants with moderate-to-severe HS.

Hidradenitis Suppurativa (HS)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Oruka Therapeutics, Inc.NCT07783542

Phase 3

A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.

Hidradenitis Suppurativa (HS)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Incyte CorporationNCT06855498

Phase 2

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial to Assess the Efficacy and Safety of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa Receiving Standard of Care Treatment

This Phase 2 study will test whether the investigational medicine, SPY072, improves hidradenitis suppurativa (HS) in adults with moderate to severe disease rec…

Hidradenitis Suppurativa (HS)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Spyre Therapeutics, Inc.NCT07766005

Phase 1

1726-nm Laser (AviClear) for Hidradenitis Suppurativa (HS): A Randomized Split-Body, Sham-Controlled Pilot Trial

Hidradenitis suppurativa (HS) is a long-lasting skin condition that causes painful lumps, abscesses, and tunnels in areas such as the armpits and groin. HS beg…

Hidradenitis Suppurativa (HS)

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Wynn Medical CenterNCT07155239

Phase 1

A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

UCB Biopharma SRLNCT06888193

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic.

Rheumatoid Arthritis (RA)Hidradenitis Suppurativa (HS)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Sonoma Biotherapeutics, Inc.NCT07123038

The Ohio State University Dermatology Biorepository

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

Hidradenitis Suppurativa

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State UniversityNCT03146676

Phase 2

A Multicenter Open-Label Interventional Biomarker Study of Lutikizumab in Adult Subjects With Moderate-to-Severe Hidradenitis Suppurativa or Adult Subjects With Moderate-to-Severe Atopic Dermatitis

Hidradenitis suppurativa (HS) and atopic dermatitis (AD) are chronic inflammatory skin diseases that lead to the development of skin lesions and symptoms such …

Hidradenitis SuppurativaAtopic Dermatitis

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT06524635

Phase 3

A Phase 3, Multicenter, Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

This is a study to evaluate the long-term safety, tolerability, and efficacy of sonelokimab in participants with moderate to severe hidradenitis suppurativa wh…

Hidradenitis Suppurativa

Estimated

~$50 – $2,100

Actual pay is set by the research site.

MoonLake Immunotherapeutics AGNCT07007637

Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease …

Hidradenitis Suppurativa

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT04115566

Phase 1

Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

HS is relatively common in the United States with a prevalence of 0.1-1.0%. 1 HS has a dramatic impact on quality of life, significantly more so than other chr…

Hidradenitis Suppurativa

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of MinnesotaNCT06058520